(Reuters) -Delaware’s highest court ruled on Thursday that patients suing drugmakers GSK, Pfizer, Sanofi and Boehringer Ingelheim cannot introduce reports from several experts to support their claim that the heartburn drug Zantac causes cancer.
The decision by the Delaware Supreme Court is a victory for the drugmakers, in a case closely watched by business groups that fear an adverse outcome could erode Delaware’s reputation as a business safe haven by encouraging mass tort litigation.
(Reporting by Jonathan Stempel in New York)
Comments